2026 MDIC Innovations in Evidence Summit
Realizing the Power of Evidence to Improve Patient Outcomes
May 5, 2026
College Park Marriott Hotel & Conference Center
Hyattsville, MD
The MDIC Innovations in Evidence Summit is the premier convening for MedTech leaders advancing real-world evidence and patient-centered innovation. Join your peers and colleagues at #InnovationsinEvidence to hear from agency leaders, industry change agents, and stakeholder partners as we explore case studies in success, examine the implications and opportunities for RWE, and generate tomorrow’s thought leadership, all guided by some of the MedTech ecosystem’s brightest visionaries.
Don’t miss your front-row seat to the future of evidence generation
Discover how MDIC can reduce risks along your path to success—featuring the latest advancements in Real-World Evidence from NEST
Note: Registration for this event is free to MDIC industry members, as well as employees of government agencies and patient organizations. MDIC partner members register at a member discount, and registration is subsidized for non-member medical device company employees. Questions? Info@MDIC.org
Explore the Summit Agenda
Explore the preliminary agenda, current as of March 12, 2026, highlighting keynote conversations, real-world evidence in action, patient impact discussions, and dedicated networking opportunities throughout the day.
Schedule-at-a-Glance
*Draft as of March 1, 2026. Subject to change.
7:00 – 8:30 AM—Breakfast Available
8:30 – 9:30 AM—Featured Keynote: Dr. Michelle Tarver, Director, CDRH, U.S. FDA
9:30 – 9:45 AM—Summit Welcome and Introductory Remarks
9:45 – 10:45 AM—Innovation Spotlight: NEST Mark—Real-World Data Source
10:45 – 11:15 AM—Networking Break
11:15 AM – 12:00 PM—Case Studies in Data Success
12:00 – 1:00 PM—Networking Lunch
1:00 – 1:45 PM—Patient Impact and Role of RWE
1:45 – 2:30 PM—Case Studies in Data Success
2:30 – 3:00 PM—Platform Launch Announce
3:00 – 3:30 PM—Networking Break
3:30 – 4:30 PM—Featured Session TBA
4:30 – 4:45 PM—Summit Closing Remarks
4:45 – 6:30 PM—Summit Networking Social
Post-Summit Workshops
Workshops held concurrently on May 6, 8:30 a.m. – 12:00 p.m.
$195 | Registration Add-On
End-to-End Evidence Strategy: A Technical Workshop for Regulatory and Payer Acceptance
This interactive workshop will examine how to develop an integrated evidence strategy that supports both FDA and CMS decision-making. Participants will compare and contrast regulatory and payer evidence expectations, explore how strategy should begin during the study planning phase, and gain insight into MDIC tools and resources designed to strengthen end-to-end evidence development across the product lifecycle.
Real‑World Evidence in Action: A Technical Workshop for Device Submissions
As real-world data (RWD) plays an increasingly critical role in regulatory decision-making, sponsors and regulators alike are seeking clearer guidance on how to reliably select, generate, analyze, and present RWD that is fit for purpose. This post-summit workshop will provide a deep, technical exploration of best practices for leveraging high-quality RWD to support regulatory submissions across the medical product lifecycle.
Building on themes and discussions from the MDIC Innovations in Evidence Summit, this interactive workshop will bring together experts from industry, solution providers, academia, and regulatory agencies to examine practical approaches to data quality assessment, study design, analytics, and documentation. Participants will engage in focused discussions and case-based examples that highlight both successful strategies and common challenges encountered when integrating real-world evidence (RWE) into regulatory packages.
The workshop will emphasize actionable insights, including how to align RWD strategies with regulatory expectations, assess data fitness for use, ensure transparency and reproducibility, and effectively communicate evidence to regulators. Attendees will leave with a clearer understanding of technical considerations and emerging best practices that can strengthen the credibility and impact of RWE-enabled regulatory submissions.
Who Should Attend
This workshop is designed for professionals involved in regulatory affairs, clinical development, biostatistics, data science, real-world evidence generation, and health outcomes research who are seeking practical, technical guidance on incorporating RWE into regulatory submissions.
Innovations in Evidence Summit Speakers
Michelle Tarver, MD, PhD
Director, Center for Devices and Radiological Health, FDA